...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: BIO-Europe 11/7
2
Nov 06, 2017 10:52AM

Nov 07, 2017 09:58AM
1
Nov 07, 2017 10:06AM
1
Nov 07, 2017 10:31AM

Nov 07, 2017 10:40AM

HL - I don't disagree with you. Since we are talking about a private company here, unless they are going to tell us that some BP has offered us an outrageous amount for the company, I don't think it's worth getting my shorts in a knot over.

tada


Nov 07, 2017 10:54AM
Share
New Message
Please login to post a reply